108 related articles for article (PubMed ID: 11478061)
1. Prognostic significance of the endothelial surface in low-grade resected oligodendrogliomas.
Vaquero J; Zurita M; Morales C; Coca S
Br J Neurosurg; 2001 Jun; 15(3):247-50. PubMed ID: 11478061
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of tumor-enhancement and angiogenesis in oligodendroglioma.
Vaquero J; Zurita M; Morales C; Coca S
Acta Neurol Scand; 2002 Jul; 106(1):19-23. PubMed ID: 12067323
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of clinical and angiogenesis-related factors in low-grade oligodendrogliomas.
Vaquero J; Zurita M; Coca S; Oya S; Morales C
Surg Neurol; 2000 Sep; 54(3):229-34; discussion 234. PubMed ID: 11118569
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.
Netto GC; Bleil CB; Hilbig A; Coutinho LM
Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas.
Calatozzolo C; Maderna E; Pollo B; Gelati M; Marras C; Silvani A; Croci D; Boiardi A; Salmaggi A
Cancer Biol Ther; 2006 Jul; 5(7):827-32. PubMed ID: 16760646
[TBL] [Abstract][Full Text] [Related]
6. Assessment of tumor angiogenesis as a prognostic factor of survival in patients with oligodendroglioma.
Quon H; Hasbini A; Cougnard J; Djafari L; Lacroix C; Abdulkarim B
J Neurooncol; 2010 Jan; 96(2):277-85. PubMed ID: 19618120
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas.
Christov C; Adle-Biassette H; Le Guerinel C; Natchev S; Gherardi RK
Neuropathol Appl Neurobiol; 1998 Feb; 24(1):29-35. PubMed ID: 9549726
[TBL] [Abstract][Full Text] [Related]
8. Quantification of sensitivity of endothelial cell markers for the astrocytoma and oligodendroglioma tumours.
Aronsson DE; Muhr C
Anticancer Res; 2002; 22(1A):343-6. PubMed ID: 12017315
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclin A and topoisomerase IIalpha of oligodendrogliomas is correlated with tumour grade, MIB-1 labelling index and survival.
Park SH; Suh YL
Histopathology; 2003 Apr; 42(4):395-402. PubMed ID: 12653952
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide synthase expression of oligodendrogliomas.
Broholm H; Braendstrup O; Lauritzen M
Clin Neuropathol; 2001; 20(6):233-8. PubMed ID: 11758777
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of endothelial surface score and MIB-1 labeling index in glioblastoma.
Vaquero J; Zurita M; Morales C; Oya S; Coca S
J Neurooncol; 2000; 46(1):11-6. PubMed ID: 10896201
[TBL] [Abstract][Full Text] [Related]
13. Histology far away from Flatland: 3D roller-coasting into grade-dependent angiogenetic patterns in oligodendrogliomas.
Cassoni P; Gaetano L; Senetta R; Bussolati B; Molinaro L; Bussolati G
J Cell Mol Med; 2008 Apr; 12(2):564-8. PubMed ID: 18182068
[TBL] [Abstract][Full Text] [Related]
14. Low-grade and anaplastic oligodendrogliomas: differences in tumour microvascular permeability evaluated with dynamic contrast-enhanced magnetic resonance imaging.
Jia Z; Geng D; Liu Y; Chen X; Zhang J
J Clin Neurosci; 2013 Aug; 20(8):1110-3. PubMed ID: 23673143
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with World Health Organization grade 2 oligodendroglioma.
Reis-Filho JS; Faoro LN; Carrilho C; Bleggi-Torres LF; Schmitt FC
Cancer; 2000 Feb; 88(4):862-9. PubMed ID: 10679656
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in oligodendroglioma.
Schiffer D; Dutto A; Cavalla P; Bosone I; Chiò A; Villani R; Bellotti C
Can J Neurol Sci; 1997 Nov; 24(4):313-9. PubMed ID: 9398978
[TBL] [Abstract][Full Text] [Related]
17. Mitotic index, microvascular proliferation, and necrosis define 3 pathological subgroups of prognostic relevance among 1p/19q co-deleted anaplastic oligodendrogliomas.
Figarella-Branger D; Mokhtari K; Dehais C; Carpentier C; Colin C; Jouvet A; Uro-Coste E; Forest F; Maurage CA; Vignaud JM; Polivka M; Lechapt-Zalcman E; Eimer S; Viennet G; Quintin-Roué I; Aubriot-Lorton MH; Diebold MD; Loussouarn D; Lacroix C; Rigau V; Laquerrière A; Vandenbos F; Michalak S; Sevestre H; Peoch M; Labrousse F; Christov C; Kemeny JL; Chenard MP; Chiforeanu D; Ducray F; Idbaih A; Delattre JY;
Neuro Oncol; 2016 Jun; 18(6):888-90. PubMed ID: 27175000
[No Abstract] [Full Text] [Related]
18. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
Kleinschmidt-DeMasters BK; Hashizumi TL; Sze CI; Lillehei KO; Shroyer AL; Shroyer KR
J Clin Pathol; 1998 Apr; 51(4):284-93. PubMed ID: 9659240
[TBL] [Abstract][Full Text] [Related]
19. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
Heesters MA; Koudstaal J; Go KG; Molenaar WM
J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical markers for prognosis of oligodendroglial neoplasms.
Korshunov A; Golanov A; Sycheva R
J Neurooncol; 2002 Jul; 58(3):237-53. PubMed ID: 12187958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
